FBXW26 Inhibitors
FBXW26 inhibitors represent a class of small molecules or compounds that interfere with the function of FBXW26, a member of the F-box protein family. F-box proteins are components of the ubiquitin-proteasome system, where they act as substrate recognition subunits of SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complexes. FBXW26 specifically is involved in tagging certain proteins for ubiquitination, which signals them for degradation by the proteasome. Inhibitors targeting FBXW26 likely function by disrupting its ability to bind to its target substrates, which prevents the ubiquitination process. This can lead to the stabilization of proteins that would otherwise be degraded, potentially altering cellular processes regulated by the specific substrates targeted by FBXW26.
These inhibitors may be designed based on the structural characteristics of FBXW26 and its interactions with both SKP1 and target proteins. Such compounds can be optimized for their affinity to the F-box domain or to other functional regions of the protein involved in the recruitment or recognition of substrates. Disruption of FBXW26 activity can lead to an accumulation of certain proteins within the cell, influencing pathways linked to protein turnover, cell cycle regulation, or signal transduction. Understanding the mechanistic basis of FBXW26 inhibitors requires a deep investigation into the substrates involved and the broader role of this F-box protein within the proteostasis network. Through inhibition of this particular ubiquitin ligase component, researchers can explore novel aspects of cellular function and regulation, particularly in the context of protein degradation and stability.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin, a direct inhibitor, disrupts Fbxw26 by inhibiting calpain, a calcium-dependent protease. This prevents calpain-mediated cleavage of Fbxw26, preserving its stability and impeding its degradation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Acting as an indirect inhibitor, Wortmannin targets Fbxw26 through the PI3K/AKT signaling pathway. By inhibiting PI3K, it hinders AKT activation, leading to downstream modulation of Fbxw26 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a direct inhibitor, disrupts Fbxw26 by blocking the proteasome function. This prevents the ubiquitin-mediated degradation of Fbxw26, maintaining its intracellular levels and inhibiting its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Acting as an indirect inhibitor, SP600125 targets Fbxw26 through the JNK signaling pathway. It inhibits JNK activity, impacting the phosphorylation of specific transcription factors and modulating Fbxw26 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an indirect inhibitor, influences Fbxw26 through histone deacetylase inhibition. By blocking HDAC activity, it alters chromatin accessibility, affecting the transcriptional regulation of Fbxw26. | ||||||
GSK461364 | 929095-18-1 | sc-364504 sc-364504A | 10 mg 50 mg | $500.00 $1540.00 | ||
GSK461364 serves as an indirect inhibitor, affecting Fbxw26 through the CDK1/cyclin B pathway. By inhibiting CDK1, it modulates the cell cycle, influencing the expression and function of Fbxw26 in a cell-cycle-dependent manner. | ||||||
Necrostatin-1 | 4311-88-0 | sc-200142 sc-200142A | 20 mg 100 mg | $94.00 $343.00 | 97 | |
Necrostatin-1, an indirect inhibitor, targets Fbxw26 through the RIPK1-dependent necroptosis pathway. By inhibiting RIPK1, it influences cell death pathways, indirectly modulating Fbxw26 expression and activity. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Acting as an indirect inhibitor, CHIR-99021 influences Fbxw26 through the GSK-3β/β-catenin signaling pathway. It inhibits GSK-3β, impacting β-catenin stabilization and downstream modulation of Fbxw26 expression. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 serves as an indirect inhibitor, targeting Fbxw26 through the NF-κB signaling pathway. By inhibiting IκBα phosphorylation, it influences NF-κB activity, leading to altered Fbxw26 expression and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059, an indirect inhibitor, targets Fbxw26 through the MEK/ERK signaling pathway. By inhibiting MEK, it disrupts the phosphorylation cascade, influencing the downstream ERK activity and modulating Fbxw26 expression. | ||||||